ULBI Ultralife Corporation: שווי פעילות לרווח לפני ריבית, מסים ופחת
The available price action vector for Ultralife Corporation (ULBI) based on the EV/EBITDA metric, which stands at 21.34, reveals the value of developing autonomous power systems for medicine and the military that foster strong customer loyalty. The business relies on mature battery developments for special services, while the company's stability is ensured by a staff of specialized chemists and government procurement experts who value steady career growth.
פילוחי מדדים פיננסיים ומדדי שוק עבור Ultralife Corp (ULBI)
The multiple correlates the total enterprise value (market capitalization plus net debt) with operating profit before depreciation and amortization. This indicator determines asset value relative to generated cash flow, ignoring tax shields. Stable defense contracts of Ultralife Corporation (ULBI) minimize volatility risks for this metric even during a recession. The current EV/EBITDA valuation provides an objective assessment of the company's solvency and the fairness of its market price.
